The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...
A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...
NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...
Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...
Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.
It's a big, germy world out there. If you want to travel with peace of mind, learn the basics of vaccines, illnesses, and ...
The Pan American Health Organization (PAHO) is warning that a dengue strain, the DENV-3 serotype, is on the rise in the Caribbean which could lead to a potential increase in cases of the disease. It ...